LIMERICK, Ireland, Dec. 20,
2022 /CNW/ - kneat.com, inc. (TSX:
KSI) (OTC: KSIOF) ("Kneat" or "the Company"), a leader
in digitizing and automating validation processes, is pleased to
announce it has appointed Katie
Keita to lead its investor relations program. Katie will
report to Kneat's CFO Hugh Kavanagh,
who previously led the effort.
With a 20+ year career in investor relations that began as a
consultant for micro and small-cap companies and grew to encompass
global tech leaders, Katie has introduced hundreds of investors to
quality companies with solid growth trajectories and facilitated
strong, long-term and mutually beneficial connections between the
two along the way.
"As Kneat continues to broaden our customer base across the life
sciences industry and expand our footprint within those customers,
now is an excellent time to focus on expanding our investor
community along with it," said Hugh
Kavanagh, CFO of Kneat. "Katie has built trusted
relationships with some of the best minds in the investment
community by prioritizing transparency, utility and timeliness,
which makes her a great fit for Kneat. As more companies
throughout the life sciences supply chain continue to discover and
deploy our best-of-breed software to deliver real business value,
we are keen to step up engagement with investors so more can
participate in our growth journey."
Prior to establishing Shopify's investor relations program in
2015, which she led for seven years, Katie spent nine years growing
the investor base for EMC, now Dell EMC. Katie holds a
bachelor's degree in Creative Writing from Miami University in Oxford, Ohio and an MBA from the Richard T.
Farmer School of Business at Miami
University.
About Kneat
Kneat, a Canadian company with operational headquarters in
Limerick, Ireland, develops and
markets the next-generation Kneat Gx SaaS platform. Multiple
business work processes can be configured on the platform from
equipment to computer system validation, through to quality
document management. Kneat's software allows users to author,
review, approve, execute testing online, manage any exceptions, and
post approve final deliverables in a controlled FDA 21 CFR Part 11/
Eudralex Annex 11 compliant platform. Macro and micro report
dashboards enable powerful oversight into all systems, projects and
processes globally. Customer case studies are reporting
productivity improvements in excess of 100% and a higher data
integrity and compliance standard. For more information visit
www.kneat.com
Cautionary and Forward-Looking Statements
Except for the statements of historical fact contained herein,
certain information presented constitutes "forward-looking
information" within the meaning of applicable Canadian securities
laws. Such forward-looking information includes, but is not limited
to, the relationship between Kneat and the customer, Kneat's
business development activities, the use and implementation
timelines of Kneat's software within the customer's validation
processes, the ability and intent of the customer to scale the use
of Kneat's software within the customer's organization and the
compliance of Kneat's platform under regulatory audit and
inspection. While such forward-looking statements are expressed by
Kneat, as stated in this release, in good faith and believed by
Kneat to have a reasonable basis, they are subject to important
risks and uncertainties. As a result of these risks and
uncertainties, the events predicted in these forward-looking
statements may differ materially from actual results or events.
These forward-looking statements are not guarantees of future
performance, given that they involve risks and uncertainties.
The forward-looking information in this press release does not
include a full assessment or reflection of the unprecedented
impacts of the COVID-19 pandemic occurring since the first quarter
of 2020 and the ongoing and developing resulting indirect global
and regional economic impacts. This has resulted in significant
economic uncertainty and even though the Company has to date
experienced no significant impact to its operations, any potential
impact on our future is difficult to understand or measure at this
time.
Kneat does not undertake any obligation to release publicly
revisions to any forward-looking statement, except as may be
required under applicable securities laws. Investors should not
assume that any lack of update to a previously issued
forward-looking statement constitutes a reaffirmation of that
statement. Continued reliance on forward-looking statements is at
an investors' own risk.
SOURCE kneat.com, inc.